EODData

MEMBERSHIP REGISTER LOG IN

SHG, 603590: Beijing Konruns Pharmaceutical Co Ltd

26 Jun 2026
LAST:

28.13

CHANGE:
 0.87		OPEN:
28.69		HIGH:
29.30		ASK:
0.00		VOLUME:
2.16M
CHG(%):
3.00		PREV:
29.00		LOW:
27.95		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
26 Jun 2628.6929.3027.9528.132.16M
25 Jun 2630.0030.1428.3429.002.94M
24 Jun 2630.3530.8930.1330.403.49M
23 Jun 2628.9930.7828.8130.414.12M
22 Jun 2629.1829.2727.8929.193.11M
18 Jun 2628.9929.9528.6229.472.23M
17 Jun 2629.1929.3728.8729.141.33M
16 Jun 2629.5129.6029.1529.341.7M
15 Jun 2630.0830.0929.3429.781.99M
12 Jun 2630.0430.2829.2629.932.83M

PROFILE

Name:Beijing Konruns Pharmaceutical Co Ltd
About:Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. The company offers agkistrodon acutus hemocoagulase under Suling trade name, a single-component hemocoagulase clinical hemostatic drug for surgical operations. It is also involved in the development of drug candidates, including CX1026 for the treatment of lung, liver, kidney, colon, and skin T lymphocyte cancer; CX1003, which is in phase 1 trial for the treatment of solid tumors/preferably rare tumors; ZY5301 that is in phase 3 clinical trials for the treatment of chronic pelvic pain in sequelae of pelvic inflammatory disease; KC-B173 for bleeding and prevention of bleeding during surgical or invasive procedures; and KC1036, which is in phase 2 clinical trial for the treatment of solid tumors. The company was founded in 2003 and is headquartered in Beijing, China.
Sector:Healthcare
Industry:Biotechnology
Address:No. 11, Xingsheng South Road, Beijing, China
Website:https://www.konruns.cn
ISIN:CNE1000036K3

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:110.47 
Price to Sales:7.26 
Price to Book:1.99 
Profit Margin:0.07 
Operating Margin:0.18 
Return on Assets:0.02 
Return on Equity:0.01 
Revenue:871.31M 
EBITDA:179.07M 
Shares:159.36M 
Market Cap:4.483B 

TECHNICAL INDICATORS

MA5:29.434.6%
MA10:29.484.8%
MA20:30.408.1%
MA50:34.0421.0%
MA100:37.0931.8%
MA200:42.6451.6%
RSI14:32.15 
WPR14:-100.00 
MTM14:-1.31
ROC14:-0.04 
ATR:1.17 
Week High:30.899.8%
Week Low:27.890.9%
Month High:38.2736.0%
Month Low:27.8951.6%
Year High:67.98141.7%
Year Low:27.890.9%
Volatility:30.83 

RECENT DIVIDENDS

Date Amount
09 Jun 2025$0.60
04 Jul 2024$0.30
07 Jul 2023$0.20
29 Jun 2022$0.30
31 May 2021$0.35
11 Jun 2020$0.50